المؤلفون: Willenbrock F; Department of Oncology, University of Oxford, Oxford, UK., Cox CM; Centre for Trials Research, Cardiff, UK., Parkes EE; Department of Oncology, University of Oxford, Oxford, UK., Wilhelm-Benartzi CS; Centre for Trials Research, Cardiff, UK., Abraham AG; Cross Cancer Institute, Edmonton, AB, Canada., Owens R; Oxford University Hospital NHS Trust, Oxford, UK., Sabbagh A; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Jones CM; University of Leeds & Leeds Cancer Centre, Leeds, UK., Hughes DLI; Department of Oncology, University of Oxford, Oxford, UK., Maughan T; Department of Oncology, University of Oxford, Oxford, UK., Hurt CN; Centre for Trials Research, Cardiff, UK., O'Neill EE; Department of Oncology, University of Oxford, Oxford, UK., Mukherjee S; Department of Oncology, University of Oxford, Oxford, UK. somnath.mukherjee@oncology.ox.ac.uk.

المصدر: British journal of cancer [Br J Cancer] 2021 Feb; Vol. 124 (3), pp. 581-586. Date of Electronic Publication: 2020 Oct 26.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*blood , Capecitabine/*therapeutic use , Chemokine CCL5/*blood , Chemoradiotherapy/*methods , Deoxycytidine/*analogs & derivatives , Pancreatic Neoplasms/*blood , Pancreatic Neoplasms/*therapy, Aged ; Cytokines/blood ; Deoxycytidine/therapeutic use ; Female ; Humans ; Induction Chemotherapy ; Male ; Middle Aged ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; ROC Curve ; Regression Analysis ; Treatment Outcome ; Gemcitabine